Table 1.
Results
| Authors (y) | Study Size | Type of Lymphedema (PL or SL) | Duration of Lymphedema before LVA | Intervention | Follow-up | Objective Improvement in % Patients | Subjective Improvement in % Patients |
|---|---|---|---|---|---|---|---|
| Yang et al24 | 26 | PL and SL | 6 y | LVA (+conservative therapy) | 6 mo | ||
| Cha et al16 | 42 | PL and SL | 8.8 y | LVA (+conservative therapy) | Minimum of 8 mo | 100 | 100 |
| Yoshida et al26 | 74 | PL | 6.1 y | LVA (+conservative therapy) | 6 mo | ||
| Scaglioni et al22 | 7 | PL and SL | Superficial and deep LVA | 9.43 mo | 100 | 100 | |
| Yoshida et al26 | 28 | PL | 3 y | LVA, great saphenous vein stripping (+conservative therapy) | |||
| Onoda et al20 | 21 | PL and SL | Multisite LVA (+complex decongestive physiotherapy) | 31 mo | 85.7 | ||
| Pak et al21 | 160 | SL | LVA, lymph node to vein anastomosis | 23.3 mo | |||
| Yoshida et al26 | 50 | SL | LVA (+conservative therapy) | 6 mo | 100 | ||
| Kim et al19 | 69 | PL and SL | 5. 26 y | LVA | 11.2 mo | 69.9 | |
| Drobot et al17 | 39 | PL and SL | 6.69 y | LVA | 7.26 mo | 100 | |
| Hara et al18 | 34 | PL and SL | 7.5 y | LVA | 8.6 mo | 83.3 | |
| Kristiansen et al30 | 12 | PL and SL | 4 y | End-to-end LVA | 12 mo | 42 | |
| Tsai et al32 | 100 | PL and SL | LVA | 9.8 mo | |||
| Yang et al33 | 100 | PL and SL | 4.8 y | LVA (+conservative therapy) | 6 mo | ||
| Bianchi et al28 | 12 | SL | LVA | 9 mo | 100 | ||
| Akita et al27 | 106 | LVA, venoplasty | |||||
| Yoshida et al34 | 12 | PL and SL | 1.66 y | LVA (+conservative therapy) | 14.5 mo | 100 | |
| Qui et al31 | 15 | PL and SL | End-to-end and end-to side LVA | 25 mo | 46.7 | 84 | |
| Cheng et al29 | 10 | PL and SL | 1 y | Side-to-end LVA (+conservative therapy) | 37.5 mo | 100 | |
| Yoshida et al34 | 113 | PL and SL | 6.4 y | LVA (+conservative therapy) | 20.6 mo |